ITF2357 company Pages on BioPortfolio:

BioPortfolio - ITF2357 company
orencia in pJIA | ITF2357 company | ITF2357 patent arthritis | juvenile rheumatoid arthritis logo | . Browse BioPortfolio's InDepth service . ...
http://www.bioportfolio.com/search/ITF2357_company.html...

BioPortfolio - biotec italia
BioPortfolio - biotec italia BioPortfolio - pharmaceutical company, New delhi, India ... The Histone Deacetylase Inhibitor ITF2357 Reduces Production of . ...
http://www.bioportfolio.com/search/biotec_italia.html...

BioPortfolio - Schnitzler Syndrome
Promote your company here: BioNewsCast - Press Release Distribution. →View more news. ... The Efficacy and Safety of ITF2357 in AIS ...
http://www.bioportfolio.com/indepth/Schnitzler_Syndrome.html...

BioPortfolio - JAK2 - Janus kinase 2 (a protein tyrosine kinase)
Promote your company here: BioNewsCast - Press Release Distribution ... Phase IIA Study of the HDAC Inhibitor ITF2357 in Patients With JAK-2 V617F Positive
...
http://www.bioportfolio.com/gene/3717-JAK2.html...

Results from other life science and pharmaceutical sites:

Leukemia - The histone deacetylase inhibitor ITF2357 has anti ...
We next investigated whether ITF2357 was still cytotoxic for MM and AML cells even when stimulated by MSCs in the co-culture system. ...
http://www.nature.com/leu/journal/v21/n9/full/2404860a.html...

Oncogene - Selective anti-leukaemic activity of low-dose histone ...
In conclusion, ITF2357 emerged as an anti-leukaemic agent very potent on AML cells, ..... and delocalization of the DNA-bound oncogene–co-repressor complex,
...
http://www.nature.com/onc/journal/v27/n12/full/1210820a.html...

HDAC inhibitors as anti-inflammatory agents
Transcriptional co-activators possess intrinsic histone ... Interestingly, when cells were stimulated with IL-12 plus IL-18, ITF2357 reduced IFNγ and IL-6 ...
http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=20...

British Journal of Pharmacology - HDAC inhibitors as anti ...
This tags histones for the subsequent recruitment of other co-activators and .... The histone deacetylase inhibitor ITF2357 reduces production of ...
http://www.nature.com/bjp/journal/v150/n7/full/0707166a.html...

The histone deacetylase inhibitor ITF2357 has anti...[Leukemia ...
... ITF2357 was still strongly cytotoxic for the interleukin-6 (IL-6)-dependent MM cell line CMA-03, or for AML samples maximally stimulated by co-culture ...
http://www.ncbi.nlm.nih.gov/pubmed/17637810...

Leukemia - Abstract of article: The histone deacetylase inhibitor ...
The histone deacetylase inhibitor ITF2357 has anti-leukemic activity in vitro and ... or for AML samples maximally stimulated by co-culture on mesenchymal ...
http://www.nature.com/leu/journal/v21/n9/abs/2404860a.html...

caspase-3 (E-8) Antibody sc-7272
Home What\'s New Support Company Shop Contact .... anti-leukaemic activity of low-dose histone deacetylase inhibitor ITF2357 on AML1/ETO-positive cells. ...
http://www.scbt.com/datasheet-7272-caspase-3-e-8-antibody.ht...

Determination of the class and isoform selectivity...[Biochem J ...
... 87a Milton Park, Abingdon, Oxon, OX14 4RY, UK. nagmabkhan@yahoo.co.uk ... ITF2357, vorinostat and belinostat) were potent pan-HDAC inhibitors. ...
http://www.ncbi.nlm.nih.gov/pubmed/17868033...

Home Marketing Services News Reports Company Profiles InDepth Drug Discovery Careers Conferences Videos Search Contact
	Nothing in this website should be used in place of personal medical advice from your own qualified medical practitioner. See User Agreement Send comments and feedback to: Peter Barfoot Managing Director, BioPortfolio Ltd. UK Tel: (+44) 1300 321501 USA Voicemail and Fax: (+1) 415 680 2472	All rights reserved. All other trademarks recognized. BioPortfolio Limited is registered in England & Wales at Wessex Barn, Dorchester Road, Frampton, Dorset, DT2 9NB, UK. No.3312883 VAT No. GB 744 6483 10 Copyright 1997-2008 - BioPortfolio Limited.